New Once-Weekly HIV Treatment Shows Promise in Clinical Trials

An investigational once-weekly HIV treatment has shown promise in clinical trials, potentially offering a more convenient option compared to current daily oral medications. While the treatment remains investigational and developers are expected to submit data to regulatory authorities, its reduced frequency could improve adherence for some patients.